AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Healingmaps

Published November 3, 2026 · Updated November 4, 2026

Psychedelic Panic Calls: Cannabis Leads, Not Psilocybin - HealingMaps

Read the full story at Healingmaps

psychedelics , which drug would generate the most panic? Five years of calls give an answer, and it is not psilocybin, LSD or any psychedelic at all.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelics